Similarly, in HCC cell lines, combinations of immune checkpoint antibodies against PD-L1, TIM3 and LAG3, which were found to be upregulated on TAA-specific CD8+ and CD4+ T cells, had additive effects in restoring the T cell response [104]. The gene discussed is CD4; the disease is hepatocellular carcinoma.